Walleye Capital’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,600	Closed	-$629K	–	5819
2024 Q3	$629K	Sell	8,600 -2,300	-21%	-$173K	0.01%	3081
2024 Q2	$747K	Buy	10,900 +10,500	+2,625%	+$728K	0.01%	3126
2024 Q1	$27.7K	Sell	400 -600	-60%	-$41.2K	﹤0.01%	4838
2023 Q4	$71.6K	Buy	1,000 +100	+11%	+$5.75K	﹤0.01%	4185
2023 Q3	$46.9K	Hold	900	–	–	﹤0.01%	4209
2023 Q2	$57K	Buy	900 +500	+125%	+$31.2K	﹤0.01%	3614
2023 Q1	$21.7K	Sell	400 -9,500	-96%	-$459K	﹤0.01%	3391
2022 Q4	$524K	Sell	9,900 -10,300	-51%	-$516K	0.01%	1421
2022 Q3	$940K	Buy	+20,200	New	+$1.06M	0.02%	1025
2020 Q1	–	Sell	-116,400	Closed	-$3.99M	–	2037
2019 Q4	$3.99M	Buy	116,400 +38,100	+49%	+$457K	0.88%	73
2019 Q3	$585K	Buy	+78,300	New	+$751K	0.39%	679
2019 Q2	–	Sell	-1,000	Closed	-$12K	–	2491
2019 Q1	$12K	Buy	+1,000	New	+$12.8K	0.02%	1394